Rxi Pharmaceuticals (NASDAQ:RXII)On June 9, 2015 shares of Rxi Pharmaceuticals went up 6% after the company reported that two new key patents were given to the company for use with their self-delivering sd-rxRNA technology platform. The new patents establish a few new details that enhance upon the company’s prospects:First the new patent is for a chemical modification that allows for […]
Biotech Stocks to BuyThis Biotech Stocks forecast is designed for investors and analysts who need predictions of the best performing stocks for the whole Biotechnology Industry (See Industry Package). It includes 20 stocks with bullish and bearish signals and indicates the best biotech stocks to buy:Top 10 biotech stocks for the long position
Top 10 biotech stocks for the short position
Package Name: […]
Today is a relatively interesting day for the biotech world; and looking at the stocks in the space, there are several possibly profitable opportunities starting to emerge. With that said, today we’re going to look at the 4 different biotech stocks that I think are presenting the largest opportunities at the moment. Here’s what I see…Aoxing Pharmaceutical Company Stock Is […]
An FDA advisory panel voted in favor of approving Regeneron (REGN – Analyst Report) and partner Sanofi’s PCSK9 inhibitor, Praluent. A few deals were also signed over the last few days by companies like Vertex (VRTX – Analyst Report), Celgene (CELG – Analyst Report) and Seattle Genetics (SGEN – Analyst Report).Recap of the Week’s Most Important Stories1. Regeneron and Sanofi […]
Immunogen (NASDAQ:IMGN)Shares of Immunogen soared as much as 68% on June 1, 2015 after the company reported positive results in patients with platinum-resistant ovarian cancer. There are about 21,290 cases of women who get ovarian cancer in the United States each year. The problem is that a lot of these patients that take chemotherapy treatments such as platinum and paclitaxel […]
One of our favorite biotech stocks of 2015, Organovo stock, has climbed 41% since the end of March. And that’s just the start for this revolutionary biotech investment.You see, Organovo Holdings Inc. (NYSEMKT: ONVO) is part of one of the most exciting biotech industries on the market. It’s called 3D bioprinting, and the applications are huge.Here’s a closer look at […]
The health-care sector is hot—but it’s not due just to the wild ride in booming biotech.The health-care sector as a whole has been a standout in the S&P 500, up 9 percent year-to-date through the end of May and the top sector gainer last month, with a 4 percent return. That’s compared to the S&P 500’s meager 2.3 percent for […]
Others note continued opportunity in biotech.Robert Christian, who analyzes hedge funds as head of research at K2 Advisors and Franklin Templeton Solutions, said biotech stock-focused managers stand out as one of his favorite strategies among the few dozen he tracks.Christian’s optimism rests on what he called exciting new technologies that justify higher company valuations.”Biotech used to be about making life […]
Sarepta Therapeutics (NASDAQ:SRPT)After the closing bell on May 19, 2015 shares of Sarepta Therapeutics were up as much as 38% in after-hours trading after the company reported that the FDA will allow the company to file a New Drug Application — NDA — for Eteplirsen. This drug Eteplirsen helps patients with Duchenne Muscular Dystrophy — DMD — to restore dystrophin […]
Eleven Biotherapeutics (EBIO – Snapshot Report) suffered a huge setback with its lead pipeline candidate failing in a late-stage study. Meanwhile, companies like bluebird (BLUE – Snapshot Report), Agios (AGIO – Snapshot Report) and Acceleron (XLRN – Snapshot Report) all got encouraging news on the regulatory front. Achillion (ACHN – Snapshot Report) struck a collaboration agreement with Johnson & Johnson […]
